New York; London – 15 August, 2016 - CVC Capital Partners ("CVC"), announced today that certain investors of Univar Inc., including Univar N.V., an investment vehicle managed by CVC and indirectly owned by funds advised by CVC and certain other co-investors, have agreed to sell 21 million shares of common stock of Univar Inc. CVC anticipates that the transaction will settle on August 18, 2016, subject to satisfaction of certain conditions.
A shelf registration statement (including a prospectus) for the offering to which this communication relates has previously been filed with the U.S. Securities and Exchange Commission and has become effective. Before you invest, you should read the prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information about the Company and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov.
Alternatively, copies of the prospectus and prospectus supplement, when available, may be obtained from Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected].
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Grupo GSH’S next stage of growth backed by leading global investor CVC
Mehiläinen agrees the acquisitions of Regina Maria and MediGroup and welcomes Hellman & Friedman as a new shareholder alongside CVC
CVC, Nordic Capital and ADIA complete acquisition of Hargreaves Lansdown to accelerate and enhance its transformation plan and deliver on its growth potential
Multiply Group signs landmark investment with CVC and PAI Partners to secure a controlling stake (67.91%) in Tendam, with the transaction expected to double Multiply’s operational EBITDA post-consolidation
PureHealth agrees to acquire Majority Stake in Hellenic Healthcare Group from funds managed by CVC Capital Partners and Management in EUR 2.2 Billion Transaction